Investigating the role of ascorbic acid and its transporters in medulloblastoma
Medulloblastoma is a highly malignant paediatric brain tumour, accounting for 20% of cases. Current treatment achieves a 70% 5-year-survival rate but can result in long-term neurological side effects. Treatment is further complicated by the disease’s heterogeneity, comprising four molecular subgroup...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/80646/ |